๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Efficacy of intravenous alendronate for the treatment of glucocorticoid-induced osteoporosis in children with autoimmune diseases

โœ Scribed by Yuzaburo Inoue; Naoki Shimojo; Shuichi Suzuki; Takayasu Arima; Minako Tomiita; Masanori Minagawa; Yoichi Kohno

Publisher
Springer
Year
2008
Tongue
English
Weight
102 KB
Volume
27
Category
Article
ISSN
0770-3198

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Efficacy and safety of alendronate for t
Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: A prospective multicenter study
โœ Maria Luisa Bianchi; Rolando Cimaz; Maria Bardare; Francesco Zulian; Loredana Le ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 93 KB ๐Ÿ‘ 2 views

Values are the number of patients or the mean ฯฎ SD. โ€  Behรงet's syndrome (2 patients), Wegener's granulomatosis (1 patient), and undefined connective tissue disease (2 patients). โ€ก Prednisone equivalents.

Uncertainties in the prevention and trea
Uncertainties in the prevention and treatment of glucocorticoid-induced osteoporosis
โœ Karen E Hansen; H Alexander Wilson; Carol Zapalowski; Howard A Fink; Salvatore M ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› American Society for Bone and Mineral Research ๐ŸŒ English โš– 96 KB

## Abstract Much knowledge has accrued since the 2001 American College of Rheumatology (ACR) guidelines were published to assist clinicians in the prevention and treatment of glucocorticoidโ€induced osteoporosis (GIO). Therefore, the ACR undertook a comprehensive effort to review the literature and